Midatech Pharma Plc (MTPH):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Midatech Pharma Plc (MTPH) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7885
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Midatech Pharma Plc (Midatech) is a pharmaceutical company that develops and commercializes products in oncology and other therapeutic areas. The company’s products include gelclair, oravig, soltamox and zuplenz. It conducts research and development programs in the areas of oncology, autoimmune diseases, pipeline, Q-octreotide, opsisporin, HCC, glioblastoma and diabetes vaccine. Midatech’s products are used in treatment of diabetes; rare cancers including brain, ovarian, liver and pancreatic cancer and neurological and ophthalmologic conditions. It collaborates with universities, and specialty and major pharmaceutical companies to develop its platform technologies. The company operates through its manufacturing facility in Bilbao, and research facility in Cardiff. Midatech is headquartered in Abingdon, the UK.

Midatech Pharma Plc (MTPH) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Midatech Pharma Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Midatech Pharma Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Midatech Pharma Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Midatech Pharma Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Midatech Pharma Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Midatech Pharma Plc, Medical Equipment, Deal Details 10
Venture Financing 10
Midatech Raises US$16 Million In Venture Financing 10
Q Chip Raises US$3 Million Venture Financing 11
Midatech Secures US$8.2 Million In Venture Financing 12
Private Equity 13
Kanwa Holdings to Acquire Midatech Pharma US from Midatech Pharma 13
Partnerships 15
Midatech Enters Into Joint Venture With MonoSol Rx 15
Equity Offering 16
Midatech Pharma Raises USD8 Million in Private Placement of Shares 16
Midatech Pharma to Raise USD2.7 Million in Rights Offering of Shares 17
Midatech Pharma Raises USD19.8 Million in Private Placement of Shares 18
Dara BioSciences Raises USD12.5 Million in Public Offering of Units 19
Dara BioSciences Files Registration Statement For Public Offering Of Units For Up To US$32.5 Million 20
Dara BioSciences Raises USD6 Million in Private Placement Of Shares 21
Midatech Pharma Plc – Key Competitors 22
Midatech Pharma Plc – Key Employees 23
Midatech Pharma Plc – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Joint Venture 24
Recent Developments 25
Strategy And Business Planning 25
Mar 10, 2017: Midatech Announces Successful Initial Scale-Up of Its Sustained Release Manufacturing Facility 25
Financial Announcements 26
Apr 23, 2018: Midatech Pharma: Audited financial results for the year ended 31 December 2017 26
Sep 28, 2017: Midatech Pharma: Interim results for the six months ended 30 June 2017 32
Apr 04, 2017: Midatech Pharma Announces Audited financial results for the year ended 31 December 2016 36
Jan 20, 2017: Midatech Pharma Provides Trading Update 37
Corporate Communications 38
Jun 01, 2018: Midatech Pharma: Board change 38
Mar 15, 2018: Midatech announces changes in Senior Management Team 39
Jan 02, 2018: Midatech enters into a Loan Agreement with MidCap Financial 40
Other Significant Developments 41
Jul 25, 2018: Midatech Pharma: Trading update 41
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42

List of Tables
Midatech Pharma Plc, Medical Equipment, Key Facts, 2017 2
Midatech Pharma Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Midatech Pharma Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Midatech Pharma Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Midatech Pharma Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Midatech Pharma Plc, Deals By Market, 2012 to YTD 2018 8
Midatech Pharma Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Midatech Raises US$16 Million In Venture Financing 10
Q Chip Raises US$3 Million Venture Financing 11
Midatech Secures US$8.2 Million In Venture Financing 12
Kanwa Holdings to Acquire Midatech Pharma US from Midatech Pharma 13
Midatech Enters Into Joint Venture With MonoSol Rx 15
Midatech Pharma Raises USD8 Million in Private Placement of Shares 16
Midatech Pharma to Raise USD2.7 Million in Rights Offering of Shares 17
Midatech Pharma Raises USD19.8 Million in Private Placement of Shares 18
Dara BioSciences Raises USD12.5 Million in Public Offering of Units 19
Dara BioSciences Files Registration Statement For Public Offering Of Units For Up To US$32.5 Million 20
Dara BioSciences Raises USD6 Million in Private Placement Of Shares 21
Midatech Pharma Plc, Key Competitors 22
Midatech Pharma Plc, Key Employees 23
Midatech Pharma Plc, Subsidiaries 24
Midatech Pharma Plc, Joint Venture 24

List of Figures
Midatech Pharma Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Midatech Pharma Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Midatech Pharma Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Midatech Pharma Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Midatech Pharma Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Midatech Pharma Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Midatech Pharma Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Midatech Pharma Plc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Midatech Pharma Plc (MTPH):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Laboratoire Aguettant SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Laboratoire Aguettant SA (Aguettant) is a pharmaceutical company that that focuses on the development, manufacturing and commercialisation of injectable hospital medicines. The company offers sterile injectable medicines in various dosages and pharmaceutical forms. It provides its products f …
  • Gas2Grid Ltd (GGX):石油・ガス:M&Aディール及び事業提携情報
    Summary Gas2Grid Ltd (Gas2Grid) is an oil and gas company that offers exploration and development of conventional oil and gas onshore Cebu Island in the Philippines, Aquitaine Basin in south-west France and the Canning Basin, Australia. The company explores and develops conventional oil and gas, coa …
  • International Zeolite Corp:企業の戦略・SWOT・財務分析
    International Zeolite Corp - Strategy, SWOT and Corporate Finance Report Summary International Zeolite Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Angelini Group:製薬・医療:M&Aディール及び事業提携情報
    Summary Angelini Group (Angelini) manufactures, markets and distributes pharmaceutical and healthcare products. The company operates in prescription and over-the-counter (OTC) pharmaceutical sectors with focus on pain and inflammation disorders, infection control and infectious diseases and central …
  • Global Franchise Group, LLC:企業の戦略・SWOT・財務情報
    Global Franchise Group, LLC - Strategy, SWOT and Corporate Finance Report Summary Global Franchise Group, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Catabasis Pharmaceuticals Inc (CATB):製薬・医療:M&Aディール及び事業提携情報
    Summary Catabasis Pharmaceuticals Inc (Catabasis Pharmaceuticals) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes medicines for the treatment of multiple diseases. The company develops its product candidates using its proprietary safely metabolized and ratio …
  • Ghella SpA:企業の戦略・SWOT・財務情報
    Ghella SpA - Strategy, SWOT and Corporate Finance Report Summary Ghella SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Ampac Packaging, LLC:企業の戦略・SWOT・財務情報
    Ampac Packaging, LLC - Strategy, SWOT and Corporate Finance Report Summary Ampac Packaging, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Hillenbrand, Inc.:企業の戦略・SWOT・財務情報
    Hillenbrand, Inc. - Strategy, SWOT and Corporate Finance Report Summary Hillenbrand, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Exelon Corporation (EXC):電力:M&Aディール及び事業提携情報
    Summary Exelon Corporation (Exelon) is a utility services holding company operating across the energy value chain comprising power generation, distribution, transmission and energy sales. It generates electricity from diverse sources, including nuclear, fossil fuels and renewable energy. Exelon deli …
  • Surgutneftegas (SNGS):企業の財務・戦略的SWOT分析
    Surgutneftegas (SNGS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Lear Corporation (LEA):企業の財務・戦略的SWOT分析
    Lear Corporation (LEA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Immunicum AB (IMMU):製薬・医療:M&Aディール及び事業提携情報
    Summary Immunicum AB (Immunicum) is a biopharmaceutical company that focuses on the development of immuno-oncology therapies for the treatment of solid tumors. The company’s lead development candidate, ilixadencel is in clinical trials for the treatment a range of solid tumors including hepatic cell …
  • CAT Telecom Public Co Ltd:企業の戦略的SWOT分析
    CAT Telecom Public Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Chesapeake Energy Corporation:企業の戦略・SWOT・財務情報
    Chesapeake Energy Corporation - Strategy, SWOT and Corporate Finance Report Summary Chesapeake Energy Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Microbix Biosystems Inc (MBX):企業の財務・戦略的SWOT分析
    Summary Microbix Biosystems Inc (Microbix) provides biological and technology solutions for human health and wellbeing. The company's products include infectious disease antigens and quality assessment products. It manufactures viral and bacterial antigens and reagents for the diagnostics. Microbix …
  • Harland Medical Systems Inc-医療機器分野:企業M&A・提携分析
    Summary Harland Medical Systems Inc (Harland Medical) is a medical equipment provider that offers medical device coatings. The company offers test equipment, coating systems, laser equipment and dispensing equipment. Its products comprise lubricent UV hydrophilic coatings, bacticent antimicrobial co …
  • Miragen Therapeutics Inc (MGEN):企業の財務・戦略的SWOT分析
    Miragen Therapeutics Inc (MGEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Tokyo Electric Power Company Holdings Incorporated (9501)-エネルギー分野:企業M&A・提携分析
    Summary Tokyo Electric Power Company Holdings, Incorporated (TEPCO), formerly Tokyo Electric Power Company, Incorporated, is an integrated energy company. The company generates, transmits, distributes and sells electricity through its subsidiaries. It generates power from various sources such as the …
  • VERBIO Vereinigte BioEnergie AG (VBK):企業の財務・戦略的SWOT分析
    VERBIO Vereinigte BioEnergie AG (VBK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆